ArticleMedicine2017

EGFR mutation testing in blood for guiding EGFR tyrosine kinase inhibitor treatment in patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis.

Jin-Qiu Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.